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Introduction 54
Patellofemoral joint osteoarthritis (PFJ OA) remains an under-recognized category of arthritis.
55
Evident in almost 70% of adults with knee pain [1] [2] [3] [4] [5] , it is more prevalent than tibiofemoral (TFJ) OA [1-3, 56 5, 6] . Patellofemoral OA is observed early in the trajectory of knee OA disease process [7] , and is 57 observed in 55% of people aged under 50 years [3] . Since the PFJ contributes more to the symptoms 58 of knee OA than the TFJ [4, 8, 9] , PFJ OA can adversely affect quality of life, economic productivity and 59 daily function in younger adults with critical career and childcare responsibilities.
61
Clinical guidelines prioritise conservative (non-pharmacological) treatments as a first line knee OA 62 management and recommend tailoring treatments to the location of joint damage [10] [11] [12] (i.e., to the
63
PFJ compartment for individuals with PFJ OA). Many trials have evaluated physical therapies for
64
patients with predominantly TFJ OA [13] . It is notably that PFJ OA severity limited the effectiveness of 65 exercise and manual-therapy applied to those with predominant TFJ OA [14, 15] , supporting the 66 recommendation for targeted interventions. Only two clinical trials specifically assessed treatments
67
for PFJ OA, with no positive effects reported for either combined exercise therapy with patellar 68 taping [16] or patellofemoral bracing [17] . The lack of benefit may reflect the lack of tailoring of exercise
69
and patellar taping to the individual [16, 17] or the use of a single treatment component (bracing) [17] .
71
The Consensus Statement from the 3rd International Patellofemoral Research Retreat [18] suggested a 72 disease continuum that manifests as PFJ pain in younger adults and PFJ OA at later stages [19, 20] .
73
Common impairments include patellar malalignment [21] [22] [23] , quadriceps and hip muscle weakness [24] [25] [26] [27] [28] [29] .
74
This provides a rationale to consider treatments designed for PFJ pain in younger adults for older
75
people with PFJ OA. Our previous clinical trials proved the effectiveness of quadriceps and hip 76 muscle retraining exercises, patellar taping, and patellar mobilisation for PFJ pain in younger 77 adults [30, 31] .
78
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We aimed to evaluate whether a PFJ-targeted program that combined (i) exercise, (ii) education, (iii) 80 manual therapy and (iv) taping, results in greater improvements in patient rated change, pain and 81 physical function than physiotherapist-delivered OA education in participants with symptomatic and 82 radiographic PFJ OA. We hypothesised that the PFJ-targeted program of exercise, education,
83
manual-therapy and taping would be superior to the OA-education at 3 months, and that beneficial 84 effects would not be present at 9-months.
86
Methods 87
Design Overview
88
We conducted a randomised, assessor-and participant-blinded controlled clinical trial, as described 89 previously [32] . The trial was prospectively registered in the Australian New Zealand Clinical Trials
90
Registry (ACTRN12608000288325). The study had ethical approval (HREC number: 0721163) and all
91
participants provided written informed consent prior to commencement, and all human testing
92
procedures undertaken conformed to the standards of the Declaration of Helsinki.
94
Setting and Participants
95
The clinical trial was conducted in primary care physiotherapy practices. Volunteers from the greater
96
Melbourne (Australia) area responded to advertisements in print and radio media, posters in 97 sporting clubs, health and medical practices and referrals from practitioners. Potential participants 98 underwent telephone screening, followed by a physical screening by an experienced physiotherapist
99
and standardised weight-bearing semi-flexed, standing, posteroanterior and skyline radiographs to 100 assess the severity of TFJ and PFJ OA.
102
To be included, volunteers were required to be aged at least 40 years; have anterior or retro-patellar
103
pain that was aggravated by two or more PFJ-loaded activities (e.g. stair ambulation, rising from 104 sitting or squatting); have an average pain score of at least 3 on an 11-point scale (0=no pain; M A N U S C R I P T
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10=worst pain possible) during aggravating activities and on most days during the past month; and
106
have evidence of lateral PFJ osteophytes [33] on weight-bearing skyline radiographs [34] . Participants
107
were excluded if they had pain from other lower-limb sites; predominantly TFJ joint symptoms on
108
clinical examination (e.g. location of pain, tenderness on palpation); current or previous (prior 12 109 months) physiotherapy for knee pain; recent knee injections (prior 3 months); previous or planned
110
(following 6 months) knee surgery; physical inability to undertake testing; other medical conditions;
111
inability to understand written and spoken English; and a body mass index (BMI) greater than 34 112 kg.m -2 . Additionally, individuals with medial > lateral PFJ osteophytes or moderate-to-severe 113 concomitant TFJ OA (Kellgren and Lawrence [35] grade >2) were excluded.
115
Randomisation and Interventions
116
The randomisation sequence (computer-generated permuted blocks of 8 to 12) was generated a 117 priori and kept external (University of Queensland) to the administration site (University of
118
Melbourne) by an independent investigator. Participants were randomly allocated to either exercise,
119
education, manual-therapy and taping or OA-education and were informed that two types of 120 physiotherapist-delivered treatments were being compared, but the types of intervention and study 121 hypotheses were concealed. A research assistant, not involved in outcome assessment, revealed the 122 allocation to the physiotherapist delivering the intervention following baseline assessment and prior
123
to the first appointment.
125
Each participant attended the private practice of one of eight trained project physiotherapists, at
126
various Melbourne metropolitan sites. Physiotherapists were experienced in treating patients with
127
knee and PFJ conditions and underwent 6 hours of training (with KMC) to standardise the treatment 128 elements and their prescription, as described in the published protocol [32] . Physiotherapists provided
129
both the active and control interventions and thus were not blinded to group allocation. Eight
130
treatments (approximately 60 minutes duration) were provided once a week for 4 weeks and then M A N U S C R I P T
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once every two weeks for 8 weeks for each group. The interventions have been described in detail 132 previously [32] .
134
The PFJ-targeted exercise, education, manual-therapy and taping program was standardised to 
156
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Participants in both groups were encouraged to continue regular physical activity that did not 158 provoke their pain. The use of adjunctive treatments (including prescription and over-the-counter 159 medicines) were permitted and recorded in weekly log books.
161
Outcome measurements
162
A blinded examiner administered all outcome measures. In those with bilateral symptoms, the most 163 symptomatic eligible knee was assessed. Participant characteristics were recorded at baseline. The 
168
Primary outcomes were patient-perceived global rating of change (from baseline) on a 5 point Likert
169
scale (5=much worse; 4=worse; 3=same; 2=improved; 1=much improved) [30] , knee pain severity
170
during an aggravating activity on a 0-100mm visual analogue scale (VAS) [32] and the activities of daily 171 living (ADL) subscale of the Knee injury and Osteoarthritis Outcome Score (KOOS) [36] . The KOOS-ADL
172
subscale is identical to the physical function subscale of the Western Ontario and McMasters
173
Universities Osteoarthritis Index (WOMAC) [37] , and a normalised score was calculated (100
174
represents no symptoms and 0 represents maximum symptoms). Secondary outcome measures 175 included the pain, symptoms, sport and recreation and quality-of-life subscales of the KOOS.
176
Adherence was measured from attendance at physiotherapy and completion of home exercise log 177 books. Adverse events and medication use were recorded in log books. Participants were considered 178 to be adherent with the home exercises if they completed 3 of the required 4 times per week (i.e.
179
75%).
181
Sample size M A N U S C R I P T
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Based on our previous RCT of PFJ-targeted physiotherapy for PFJ pain [31] 
227
At 9-months, more people in the exercise, education, manual-therapy and taping group than in the 228 OA-education group reported being much improved (relative risk 3.26 (95% CI 1.46 to 7.26); NNT 3
229
(95%CI 2 to 7)) (Fig 2) . However, imputing missing data (21%) on a worse-case scenario, the results
230
were no longer statistically significant. No significant between-group differences were observed for 231 participant-reported knee pain (10.5 mm; 95% CI -1.8 to 22.7), KOOS-ADL (3.0; 95% CI -3.7 to 9.7).
233
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At 3-months, the exercise, education, manual-therapy and taping intervention and the OA-education 235 control resulted in similar outcomes for all secondary outcome measures (Table 3) except for KOOS-236 pain, where those in the exercise, education, manual-therapy and taping group reported significantly 237 greater reductions in KOOS-pain than those in the OA-education group (6.0; 95% CI 0.1 to 12.6).
238
After 6-months of no treatment, there were no significant between-group differences (Table 3) .
240
Adherence, adverse events, and co-interventions
241
No significant differences were observed between groups for attendance (mean (SD) number of 
262
Our study fills a gap in the literature, where most evidence exists for medial TFJ OA. The importance 263 of our targeted intervention is underpinned by recent recommendations to tailor non-264 pharmacological management for knee OA [10] . Considering that approximately 70% of people aged 265 above 50 with knee pain with or without radiographic OA have PFJ involvement, and the differences 266 between the PFJ and TFJ compartment in joint biomechanics [39] , risk factors for disease progression 267 [40, 41] and symptomatic presentations [27, 29, 42] , a PFJ OA-focussed intervention is appropriate.
268
Furthermore, people with PFJ OA derive lesser benefits than those with TFJ OA from a non-specific 269 exercise therapy [14] that does not consider the unique functional and biomechanical impairments 270 associated with PFJ OA. Our study shows that three patients with PFJ OA would need to be treated 
280
tailoring the prescription and progression of exercises to individual abilities and co-morbidities.
281
Patellar malalignment, a prominent feature of PFJ OA [21] [22] [23] , was assessed for each individual and
282
addressed with patient-specific mobilisations and taping.
283
284
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The lack of benefit following an additional 6 months of no treatment might indicate that 285 interventions involving exercise, education, manual-therapy and taping for this patient population 286 need to be extended. The targeted physiotherapy group was instructed to maintain their home 287 exercise programme. However, the programme was not supervised or progressed over the following 288 6 months. Furthermore, adherence to the unsupervised programme is unknown. Considering that
289
OA is a chronic disease, our results indicate the need for trials with either an extended supervised 290 treatment duration, or additional means to ensure adherence to an unsupervised programme.
292
This study has a number of important strengths. To facilitate recruitment of those with predominant
293
PFJ OA, our eligibility criteria included history, examination and radiographic criteria. The studied 
301
There are some limitations to our study, with the main one being a loss of 21% of participants to 302 follow up at 9-months. The worse-case scenario imputation for missing data implemented in the 303 analysis lead to a conclusion of no benefit of exercise, education, manual-therapy and taping over 
337
The physiotherapists who delivered the physiotherapy and control treatments were Ann Ryan, Participants lost to follow-up at 3 months were not followed up at 9 months [35] for the tibiofemoral joint measured from an anteroposterior radiograph)
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PFJ O/P severity: Severity of lateral patellar osteophyte measure from a skyline x-ray [33] M A N U S C R I P T • Declined to participate (n= 49 )
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Allocationpatients
Randomized (n=92)
Enrollment
Attended for physical and radiographic screening (n= 227)
Excluded (n=135)
• Not meeting clinical inclusion criteria (n= 10)
• Not meeting radiographic criteria (n= 121) • Declined to participate (n= 4)
Allocated to targeted physiotherapy (n=44)
• Received allocated intervention (n=40)
• Did not receive allocated (n=4)
-could not attend all physiotherapy sessions
Physiotherapists (n=8)
• One physiotherapist per centre
• Number of participants treated by each therapist (median 6; IQR [4] [5] [6] [7] [8] Assessed for eligibility via telephone (n= 365)
• Number of participants treated by each therapist (median 5; IQR 4-10)
Lost to follow-up (n=6)
Analysed (n= 42 )
Allocationphysiotherapists 3 month assessment
Allocated to OA-education (n=48)
• Received allocated intervention (n= 46)
• Did not receive allocated intervention (n=2) 
Background
Osteoarthritis (OA) is the leading cause of musculoskeletal pain and disability and is the third leading cause of lifeyears lost due to disability in Australia, only behind depression and dementia [1] . The annual total cost of arthritic disease in Australia is estimated at $24 billion [2] , with the knee joint contributing substantially to this overall cost. The prevalence of OA in people aged over 55 years is 20-26% and rising, with arthritis rates expected to increase by 30% over the next 40 years [2] . The pain and suffering endured by patients as a result of OA decreases their quality of life, with the annual burden of disease costs ($12 billion in Australia) being half the total costs associated with this condition [2] . Pain associated with daily activities such as walking and stair-climbing ultimately leads to profoundly reduced functional independence [2] .
The patellofemoral joint (PFJ) is one of the three knee joint compartments. Awareness of its importance in the OA process has been raised by the increasing use of lateral and skyline x-rays in recent times. Research has revealed that PFJ OA is more common than previously thought. In a community-based study of knee OA (N = 218), the frequency of radiographic osteophytes was greater in the PFJ (65% knees) than in the tibiofemoral joint (TFJ) (55% knees) [3] . Furthermore, in people with knee pain (N = 777), the most common compartmental distribution of radiographic OA was a combination of TFJ and PFJ disease (40%), followed by isolated PFJ OA (24%), and isolated TFJ disease (4%) [4] . Within the PFJ, the lateral compartment is more frequently affected by the OA process than the medial [5, 6] . Importantly, the presence of baseline PFJ OA predicts structural deterioration in the TFJ compartment over 30 months (OR 2.31, 95% CI 1.37, 3.88) [7] .
The PFJ is an important source of symptoms associated with knee OA [8] . Knee pain has been found to be significantly associated with PFJ osteophytes (OR 2.25, 95%CI 1.06, 4.77), but not TFJ osteophytes (OR 1.19, 95% CI 0.46, 3.09) [9] , suggesting that the PFJ may be a more important source of knee pain than the TFJ. Hunter et al [10] noted that increased pain and poorer function was associated with reduced cartilage volume in the patella, but not in the femur nor the tibia. Other authors have confirmed the relationship between radiographic PFJ OA and knee pain [11] [12] [13] .
Management strategies for knee OA have traditionally focussed on alleviating symptoms, primarily using drug therapies or surgery. A meta-analysis of OA trials highlights this, with most trials evaluating drug treatments (60%) or surgical procedures (26%) [14] . OA experts have highlighted the overall dearth of quality evidence to support the use of non-pharmacological interventions such as physiotherapy. Despite this, knee OA clinical guidelines recommend that conservative treatments be included as a first line strategy for the optimal management of the disease [15, 16] . Physiotherapy is a conservative intervention, which is non-toxic, inexpensive and promotes physical activity and self management through exercise. Therefore, rigorous randomised clinical trials (RCTs) that evaluate the efficacy of physiotherapy are clearly needed, to better guide clinical decision-making.
Given the heterogeneity of knee OA with regard to aetiology, clinical presentation and natural history, guidelines also recommend the tailoring of knee OA treatments to the location of joint damage in order to optimise treatment outcomes [15, 16] . However, most trials of physiotherapy for knee OA have not been targeted to disease subgroups, with participant selection typically based on the presence of non-specific knee pain and radiographic changes anywhere on an anteroposterior radiograph. While a plethora of evidence attests to the benefits of exercise for patients with predominant TFJ OA [17] there is no level I evidence and only one RCT [18] specifically addressing the problem of PFJ OA. The dearth of evidence for a compartment-specific treatment for PFJ OA necessitates our proposed study to establish the efficacy of a compartment-specific physiotherapy treatment using the rigour of a RCT.
While there is little known about the physical impairments associated with PFJ OA, there are several RCTs that have evaluated physical interventions for PFJ pain in younger adults (patellofemoral pain syndrome, or anterior knee pain). We have previously conducted a double blind, placebo-controlled RCT [19] , which demonstrated the efficacy of a targeted physiotherapy program for this patient population. The targeted treatment involved (i) quadriceps muscle retraining; (ii) patellar taping; (iii) manual PFJ and soft tissue mobilisation; and (iv) hip muscle retraining. We have recently confirmed the beneficial effects of this targeted physiotherapy approach on pain and physical function in another population of young adults with PFJ pain [20] . Therefore, we are proposing to evaluate a similar, targeted physiotherapy intervention for people with PFJ OA.
This project aims to evaluate whether a physiotherapy treatment, targeted to the PFJ and based on successful treatment for PFJ pain in younger populations, results in greater improvements in pain and physical function than a physiotherapy education intervention in participants with symptomatic and radiographic PFJ OA.
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Methods
Experimental design
A randomised, single-blind, controlled clinical trial conforming to CONSORT [21] guidelines will be conducted, comparing a multimodal physiotherapy intervention to a physiotherapy education intervention (Figure 1) . A Project Investigator will screen for eligibility based on history, clinical and radiographic examination.
Ethical approval has been obtained from the University of Melbourne Human Research Ethics Committee (HREC No. 0721163) and from the Department of Human Services Victoria, Radiation Safety Committee. All participants will provide written informed consent.
Participants
Ninety people with lateral PFJ OA will be recruited from the community via advertisements, medical practitioners and our own research database. To be included in the study, participants must fulfil the following criteria: (i) aged > 40 years; (ii) anterior-or retro-patellar knee pain aggravated by at least two activities that load the PFJ (eg stair ambulation, squatting and/or rising from sitting); (iii) pain severity ≥ 4 on an 11 point numerical pain scale during aggravating activities; (iv) pain during these activities present on most days during the past month; (v) osteophyte grade ≥ 1 in the lateral PFJ compartment on skyline x-ray [22] . or joint space narrowing on a skyline x-ray) that is more severe than lateral PFJ OA; (viii) moderate to severe concomitant TFJ OA (Kellgren and Lawrence grade ≥ 3 on an anteroposterior radiograph) [23] ; (ix) knee or hip arthroplasty or osteotomy; (xi) physical inability to undertake testing procedures or; (x) inability to understand written and spoken English.
Sample Size
Treatment efficacy will be evaluated by comparing change on primary outcome measures between groups. We aim to detect the minimum clinically important improvement on these outcomes as reported by Tubach et al [24] . Specifically, a sample of 90 will provide a minimum of 90% power (α = 0.05) to detect a difference in pain on visual analogue scale (VAS) of 19.9 (21.5) mm and a difference in physical function on the Western Ontario MacMaster Universities Osteoarthritis Index (WOMAC) [25] of 9.1 (13.9) normalised units. This sample size also allows for an estimated 10% drop-out rate.
Procedure
The randomisation schedule (permuted blocks of 8 to 12) will be generated and maintained centrally by one of the investigators (BV), who will not be involved in assessment of participants. The randomisation schedule will be revealed via telephone following baseline assessment. A blinded investigator will perform outcome assessments (Table 1) at baseline, 12 weeks and 9 months, and participants will be instructed not to divulge their group allocation. Security of the blinding system will be evaluated to ensure integrity.
Outcome assessment
Age, gender, duration of knee OA symptoms, previous treatment, surgery and medication use for knee OA will be obtained at the baseline assessment.
Primary outcome measures: Pain and physical function
Overall average knee pain in the previous week on movement and during an aggravating activity nominated by the participant will be self-assessed with a 0-100 mm horizontal visual analogue scale (VAS) with terminal descriptors of (0 = no pain; 10 = maximal pain). Self-reported 
Primary Outcome Measurement
Usual pain on movement in the previous week 0-100 mm visual analogue scale (VAS) with terminal descriptors: 0 = no pain; 10 = maximal pain Usual pain during nominated aggravating activity in the previous week 0-100 mm visual analogue scale (VAS) with terminal descriptors: 0 = no pain; 10 = maximal pain Self reported difficulty with physical function Physical Function subscale of the Western and Onatario MacMasters University (WOMAC) Osteoarthritis Index (Likert version) Step test -number of times can step foot up and down off 15 cm step in 15 s
Secondary Outcomes Measurement
Other Outcomes Measurement
Physical activity levels Physical Activity Scale for the Elderly (PASE) Adherence (physiotherapy group only)
Number of physiotherapy visits Completion of home exercises via log- difficulty with physical function will be assessed using the physical function subscale of the Likert version of the WOMAC [25] . This disease-specific measure is reliable, valid and responsive and comprises 17 items, using a 5-point scale to score each, where higher scores indicate worse symptoms.
Secondary outcome measures
Pain and stiffness will be assessed using the relevant subscales of the WOMAC [25] . Participants will rate their perceived overall change in symptoms following treatment on a 5 point ordinal scale: 1-much improved, 2-improved, 3-no change, 4-worse, 5-much worse, giving a perceived global effect score. Sports and recreation function, symptoms and knee-related quality-of-life will be assessed using the relevant dimensions of the Knee Injury and Osteoarthritis Outcome Score (KOOS) [26] .
Objective measures of function will include the one-leg rise test, a timed stair ambulation test and the step-test. The one-leg rise test is the maximum number of one-leg rises the participant can perform from sitting on a stool. The participant must hold their non-test leg out straight and cannot use their arms for assistance. The number of rises that the participant can complete will be recorded. This test is a measure of lower extremity functional performance that has been found to predict the development of radiographic knee OA in middle aged people with chronic knee pain [27] . The timed stair ambulation task involves the participant ascending and descending a set of nine standard steps at their usual pace and the total time taken recorded, with longer time taken indicating poorer physical function [28] . The step-test is a functional, dynamic test of standing balance, where the participants stands on one leg in front of a 15 cm step, and places the opposite foot on and off the step as quickly as possible over 15 seconds. The total number of successful steps are recorded, with higher scores indicating better balance [29] .
Other measures
Disease severity of the TFJ from weight bearing anteroposterior knee x-rays taken at screening will be determined using the Kellgren and Lawrence grading system [23] where 0 = normal; 1 = possible osteophytes; 2 = minimal osteophytes and possible joint space narrowing; 3 = moderate osteophytes, some narrowing and possible sclerosis and; 4 = large osteophytes, definite narrowing and severe sclerosis. PFJ OA will be assessed from a skyline x-ray using a radiographic atlas [22] . The medial and lateral PFJ compartments will each be scored separately for the presence of osteophytes and joint space narrowing where 0 = normal; 1 = mild or 1-33% abnormal; 2 = moderate or 34-66% abnormal and; 3 = severe or 67-100% abnormal.
Co-interventions, adherence and adverse effects will also be recorded. Participants will be asked to refrain from other forms of OA treatment, but stable drug doses will be permitted. Physiotherapists will record attendance, details of treatment progression (physiotherapy group) and adverse events. Participants will record adherence with home exercises (physiotherapy group), adverse events and any cointerventions, including knee-related medication use in a log-book.
Interventions
Each participant will be treated by an experienced and registered physiotherapist. Treating practitioners will be trained and proficient in both of the interventions (physiotherapy and education control). Each treatment will be delivered in 8 sessions over 12 weeks (once per week for four weeks, then once every two weeks for 8 weeks). Reasonable costs associated with treatments will be met by the project.
Physiotherapy Treatment
The physiotherapy treatment will be similar to that employed in our previous RCTs for patellofemoral pain in younger people [19, 20] . Treatment will consist of (i) functional retraining exercises for the quadriceps muscle; (ii) quadriceps and hip muscle strengthening; (iii) patellar taping; (iv) manual PFJ and soft tissue mobilisation; and (v) OA education. The treatment will be tailored according to each participant's clinical presentation (eg strength, pain severity, swelling) as well as the presence of co-morbidities (eg back and hip pain or pathology), and will be progressed based on individual response to exercise load, thus optimising treatment effects. Exercises will be taught and supervised by the physiotherapist during each visit. A home exercise program will be prescribed, to be performed independently at home 4 times per week. An exercise manual for participants will be produced, with clear instructions and diagrams to ensure correct and safe performance of exercise. Specific aspects of the treatment are outlined in Table 2 and will include: (i) Functional retraining exercises for the quadriceps muscle. The muscle retraining is designed to enhance the coordination (magnitude and onset timing) of the medial quadriceps, relative to the lateral utilising biofeedback within the sessions. In order to accommodate a patient group with heterogeneous symptoms, the functional retraining exercises may be performed statically and/or dynamically during various functional activities (eg step up, step down, sit to stand).
(ii) Quadriceps and hip abduction strengthening. The exercise selection will be based on baseline capacity of the individual and then progressed, based on response to exercise load, thus maximising the training effects. Resistance will be provided by weights, rubber tubing and/or body weight. (iii) Patellar taping to reduce pain using the same standardised protocol as per our previous knee OA research [30, 31] . The tape will be applied by the physiotherapist at each visit, worn continuously for one week and then removed.
(iv) Manual PFJ and soft tissue mobilisation, comprising medial patellar glides and massage to the lateral soft tissue structures, performed by the physiotherapist.
(v) OA education covering topics such as exercise, diet, weight loss etc.
Following cessation of supervised physiotherapy sessions at 12 weeks, participants will be instructed to continue with a home exercise program. Adherence to the program will be monitored from the diary recordings of exercise completions.
Physiotherapy Education Control
In order to control for the psychosocial contact inherent with the physiotherapy treatment, participants allocated to the control group will attend individualised OA education sessions covering topics such as exercise, diet, weight loss, etc, provided by the physiotherapist with the same frequency as the physiotherapy sessions.
Data quality and management
Strategies employed to ensure data quality include: (i) training of assessors and physiotherapists; (ii) assessment of procedural quality; (iii) random checks by investigators of adherence to study protocols; and (iv) random checks of forms for completeness and data for accuracy. All analyses will be conducted on an intention-to-treat basis. The primary outcomes measured at 12 weeks and 9 months will be analysed using linear mixed regression models, including their respective baseline scores as a covariate, subjects as a random effect, treatment condition as a fixed factor and the covariate by treatment interaction. Participant characteristics (eg; gender, radiographic severity of TFJ and PFJ OA) will also be included as covariates. Regression diagnostics will be used to check for normality of the measures and homogeneity of variance, where appropriate. Comparisons between group means will be performed using Bonferroni or Newman Keuls range tests. An alpha level of 0.05 will be used. Calculation of the number needed to treat index will be performed to facilitate the development of clinical guidelines.
Discussion and Conclusion
PFJ OA is emerging as a distinct clinical entity that is common, is associated with considerable pain and disability, and is an important and novel area of research, since little is known about the optimal management of this condition. This study uses a single-blind RCT design to investigate whether a multimodal physiotherapy treatment, targeted to the PFJ, is more effective in reducing pain and improving physical function than a physiotherapy education control intervention in people with PFJ OA. As a secondary aim, it will evaluate whether the targeted physiotherapy treatment results in greater perceived improvement, self-reported stiffness, pain, sport and recreational function, symptoms and knee-related quality of life, as well as performance on functionally relevant tasks (one-leg rises, timed stair ambulation, and step-test) than the physiotherapy education control intervention. In contrast to OA primarily affecting the TFJ, comparatively little known about the features or impairments associated with OA of the PFJ, and hence designing a targeted intervention is challenging. Thus, we have chosen to investigate a physiotherapy intervention that is largely based on a program that we have previously found to be successful in younger people with PFJ pain (patellofemoral pain syndrome) [19, 20] . Components of this targeted intervention include: (i) functional retraining of the quadriceps muscle; (ii) quadriceps and hip muscle strengthening; (iii) patellar taping; (iv) manual PFJ and soft tissue mobilisation; and (v) OA education. This intervention is currently considered to be "best-practice" in the management of PFJ pain, and is increasingly being employed clinically in the management of people with PFJ OA.
An impairment that has been the subject of recent evaluation in participants with generalised knee OA is patellar malalignment. Patellar malalignment is typically exhibited as lateral patellar tilt, displacement or subluxation and may be important in PFJ OA by reducing and lateralising the PFJ contact area [32] , thus increasing stress in this compartment. In people with knee OA, PFJ malalignment has been shown to be associated with indices of OA (joint space narrowing and loss of cartilage thickness) [33, 34] as well as progression of OA (joint space narrowing) [35] in the PFJ compartment and increased functional impairment [36] . Thus, PFJ malalignment is a key feature of PFJ OA that could be amenable to a targeted intervention such as physiotherapy. This supports the inclusion of patellar tape in our targeted treatment, since it has the potential to reduce patellar malalignment [37] [38] [39] and we have already shown that patellar tape can reduce knee pain in generalised knee OA populations [30, 31] . Other treatment modalities (eg PFJ and soft tissue mobilisations), may assist in the treatment of PFJ pain and malalignment in this patient population.
The balance of medial and lateral quadriceps activity is essential to maintain PFJ alignment. Experimental studies confirm that reduced or delayed medial quadriceps activity (relative to the lateral quadriceps) increases lateral patellar malalignment, leading to areas of heightened contact stress across the lateral PFJ compartment [40, 41] . Thus, the balance of muscle activation between the medial and lateral quadriceps may be important in PFJ disease. In our studies of younger people with PFJ pain [42, 43] , we have observed a temporal delay in medial quadriceps activity. Thus, it is likely that individuals with PFJ OA may require a specific retraining program designed to restore balanced quadriceps activity.
While the role of hip muscle function in PFJ OA has not been investigated, there is increasing evidence that hip muscle function is impaired (reduced strength [44] , delayed hip muscle activity [45] ; and altered hip movements during ambulation [46] ) in other PFJ conditions. These studies indicate that hip abduction is particularly relevant in patients with PFJ pain and hence, this study is focusing on strengthening hip abduction. Furthermore, the inclusion of a hip abduction strengthening program in this study reflects contemporary clinical practice.
While the main goal of treatment for OA is to reduce pain and disability, it is not known how non-pharmacological interventions achieve this goal; such is the complex multifactorial nature of OA pain. Our intervention is based on reversing the compartment-specific impairments likely to be associated with PFJ OA. Furthermore, this intervention builds on our previous studies, which have established that: (i) taping the patella medially reduces pain and disability associated with non-specific knee OA [30, 31, 47] and may reduce PFJ malalignment [48] and (ii) a quadriceps retraining program can reduce pain and disability, as well as restore quadriceps muscle activation patterns in younger people with PFJ pain [19, 49, 50] . Our unique RCT is targeting PFJ OA, an important sub-group of knee OA, with a specifically designed intervention. The project's outcome will influence knee OA rehabilitation, thus reducing the personal and societal burden of this increasing public health problem. 
